Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 5, 2000, Pages 105-110

  Bianchi, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ALDOSTERONE RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; CREATININE; DIGITALIS LIKE FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; LOOP DIURETIC AGENT; METHYLDOPA; RENIN; RENIN INHIBITOR; SODIUM; THIAZIDE DIURETIC AGENT;

ANEMIA; ANGIONEUROTIC EDEMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE REGULATION; BODY FLUID; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; COUGHING; DIAGNOSTIC PROCEDURE; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; HEMODIALYSIS; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY TRANSPLANTATION; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RAT; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; RISK ASSESSMENT; SURVIVAL; VASCULAR RESISTANCE;

EID: 0033791467     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_5.105     Document Type: Article

References (34)

1. Hypertension in patients with chronic renal disease
2. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis
3. An investigation of the effect of advancing uraemia, renal replacement therapy, and renal transplantation on blood pressure diurnal variability
4. Role of volume overload in dialysis-refractory hypertension
5. Factors associated with inadequate blood pressure control in hypertensive hemodialysis patients
6. Hypertension in haemodialysis patients: Who cares?
7. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients
8. Hypertension in the hemodialysis population: A survey of 649 patients
9. Hypertension in the haemodialysis population: Any relationship to 2-years survival?
10. The dominant role of the kidneys in the long-term regulation of arterial pressure in normal hypertensive states
11. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure
12. Renal artery disease in the elderly
13. Arterial hypertension in the last stage of chronic uraemia
14. The kidney and primary hypertension: Contributions from renal transplantation studies in animals and humans
15. Donor and recipient family histories of hypertension influence renal impairment and blood pressure during acute rejections
16. Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients
17. Disadvantage of long-term CAPD for preserving cardiac performance: An echocardiographic study
18. Blood pressure control in dialysis patients: Importance of the lag phenomenon
19. The effect of long, slow haemodialysis on patient survival
20. Fluid state and blood pressure control in patients treated with long and short haemodialysis
21. Effect in the conscious dog of constriction of the renal artery to a sole remaining kidney on haemodynamics, sodium balance, body fluid volume, plasma renin concentration and pressor responsiveness to angiotensin
22. Mechanisms of renal hypertension
23. Interdialytic weight gain and 48-h blood pressure in haemodialysis patients
24. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease
25. Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience
26. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
27. Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study
28. Hypertension and chronic renal failure: The use of ACE inhibitors
29. Current strategies for management of hypertension
30. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease
31. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: Is this a cause for concern?
32. Safety of the combination of valsartan and benazepril in patients with chronic renal disease
33. Duration of dialysis session
34. Treatment of hypertension in dialysis patients by ultrafiltration: Role of cardiac dilatation and time factor